Alverlind Allmänmedicin AB
ActiveKey figures
Key figures
2025Summary: Alverlind Allmänmedicin AB
What kind of company is it?
Alverlind Allmänmedicin AB (org. no. 559337-1999) is a limited company (AB). The company was registered in 2021 and has existed for 5 years. Registered seat: Östersund. Industry according to Statistics Sweden: general primary medical practice activities (SNI 86211).
How is the company doing financially?
Net sales in financial year 2025 were 115 000 kr, down 42,9 % on the previous year (201 400 kr). From 2022 to 2025, net sales declined by an average of 15,1 % per year. This is the lowest net sales among the reported years (2022–2025). Net profit for 2025 was 48 188 kr (41,9 % of net sales). The company was profitable in all 4 reported financial years. At the end of financial year 2025, total assets were 121 525 kr and equity 69 536 kr (equity ratio 57,2 %).
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 4 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Dividend
from the annual reportProposed dividend 146 300 kr.
Summary of annual reports2022–2025
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Sales revenue | 188 073 | 238 950 | 201 400 | 115 000 |
| Profit for the reporting year | 134 926 | 168 391 | 142 330 | 48 188 |
| Retained earnings of previous periods | — | — | — | — |
| Total assets | 217 687 | 310 653 | 305 820 | 121 525 |
| Total liabilities | 57 761 | 116 336 | 138 173 | 51 989 |
| Total equity | 159 926 | 194 317 | 167 647 | 69 536 |
| Employees | — | — | — | — |
| Proposed dividend | 134 000 | 169 000 | 146 300 | — |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.